Rallybio Corporation

RLYB · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$58-$75-$67-$47
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$8$11$9$4
Change in WC-$0$4-$1-$4
Other Non-Cash$1-$1$1$2
Operating Cash Flow-$49-$60-$57-$46
Investing Activities
PP&E Inv.$0-$0-$0-$0
Net Acquisitions-$2-$2-$0-$2
Inv. Purchases-$49-$111-$201-$2
Inv. Sales/Matur.$84$138$90$2
Other Inv. Act.$0$2$0-$0
Investing Cash Flow$33$28-$112-$2
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$5$0$52$86
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0$0-$0-$3
Financing Cash Flow$5$0$51$83
Forex Effect$0$0$0$0
Net Chg. in Cash-$11-$32-$118$35
Supplemental Information
Beg. Cash$24$57$175$140
End Cash$14$24$57$175
Free Cash Flow-$49-$60-$57-$46